Insider Trading disclosures for Kazia Therapeutics Ltd (ADR)
The latest disclosure was made by Robert F. Apple in Kazia Therapeutics Ltd (ADR) where a trade of 75,000
Employee Stock Option (right to buy) done
was reported to US exchanges on Jan. 8, 2026.
Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Client Name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Security Type |
|
Robert F. Apple
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jan 2026 |
75,000 |
75,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
John E. Friend
|
Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jan 2026 |
500,000 |
500,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
John E. Friend
|
Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jan 2026 |
150,000 |
150,000
|
-
|
|
-
|
Restricted Share Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges